Circulating S100A12 levels are not elevated in patients with stable coronary artery disease but are increased in those with acute coronary syndromes (ACS) and after percutaneous coronary intervention (PCI) due to acute release of S100A12 from macrophages after plaque rupture or mechanical injury (8, 9). The gene discussed is S100A12; the disease is acute coronary syndrome.